Abstract:Objective To investigate prognostic factors of more than 10 years of survival for liver cancer patients after liver transplantation. Methods From May 2000 to May 2007, a total of 134 liver cancer patients who underwent liver transplantation in the Department of Hepatobiliary Surgery, Peking University People’s Hospital, were continuously and retrospectively enrolled. The patients included 120 males and 14 females. There were 124 cases (92.5%) of primary hepatocellular carcinoma, 9 cases (6.7%) of cholangiocarcinoma, and 1 case of mixed hepatocellular carcinoma and cholangiocarcinoma. Patients with perioperative death were excluded. Follow-up was performed until May 31st, 2017 or the time of death. According to the data on postoperative survival time, patients were divided into a < 10 years group (81 cases) and a ≥ 10 years group (53 cases). Patients’ clinical data were recorded and analyzed, including alpha-fetoprotein (AFP) level (≥ 400 µg/L or < 400 µg/L), number of tumor lesions (< 3 or ≥ 3), tumor size (≤ 5 cm or > 5 cm), vascular tumor thrombus (large blood vessel or non-large blood vessel), and histological differentiation degree. The Kaplan–Meier method was used to calculate survival rates. The log-rank method was used to compare the differences between survival curves. The Cox proportional hazards regression model was used to perform multivariate analyses of possibly influential factors. Results (1) Follow-up was conducted with all 134 liver cancer patients after liver transplantation. The follow-up periods were 1–201 months, with a median of 18 (8.75, 132.5) months. The Kaplan–Meier survival analysis results showed that the 1-year, 3-year, 5-year, and 10-year cumulative survival rates were 70.3%, 48.6%, 46.8%, and 46.8%, respectively. (2) The differences in the age of patients, the incidence rate of AFP ≥ 400 µg/L, tumor histological differentiation, vascular tumor thrombi, tumor lesion size, and number of tumor lesions between two groups were all statistically significant (all P < 0.01). (3) The cumulative survival rates were different in AFP (log-rank χ 2 = 13.428), histopathologic differentiation (log-rank χ 2 = 33.592), large blood vessel tumor thrombi (log-rank χ 2 = 36.470), tumor lesion size (log-rank χ 2 = 39.835), and number of tumor lesions (log-rank χ 2 = 47.016), and there were statistically significant differences between groups (all P < 0.01). (4) Multivariate Cox proportional hazards regression analyses showed that ≥ 3 tumor lesions [hazard ratio (HR) = 2.879, 95% confidence interval (CI) 1.566–5.422], tumor lesion size > 5 cm (HR = 2.682, 95% CI 1.382–5.366), large blood vessel tumor thrombi (HR = 1.831, 95% CI 1.010–3.341), and poor histological differentiation (HR = 2.150, 95% CI 1.372–3.394), were risk factors affecting the 10-year survival of liver cancer patients after liver transplantation (all P < 0.05). Conclusion Tumor size, tumor number, large blood vessel tumor thrombi, and low tumor differentiation were all found to be independent risk factors affecting the 10-year survival rate after liver transplantation in liver cancer patients.

Tumor size assessment with ultrasound as a prognostic factor for patients with liver transplantation for hepatocellular carcinoma

Relationship Between Clinicopathologic Features and Neoplasm Recurrence,prognosis in Hepatocellular Carcinoma after Liver Transplantation

Serum levels of preoperative α-fetoprotein and CA19-9 predict survival of hepatic carcinoma patients after liver transplantation.

Tumor Existence and Tumor Size As Prognostic Factors in Hepatitis B Virus-Related Cirrhosis Patients Who Underwent Liver Transplantation

Analysis of survival and prognostic factors of liver transplantation for hepatocellular carcinoma

[Liver Transplantation for Hepatocellular Carcinoma: Prognostic Analysis of 89 Cases].

[Influence of Tumor Characteristics on the Outcome of Liver Transplantation among Patients with Hepatocellular Carcinoma].

Importance of Tumor Size at Diagnosis As a Prognostic Factor for Hepatocellular Carcinoma Survival: a Population-Based Study

Human leukocyte antigen-G and prognosis of liver transplantation in patients with hepatocellular carcinoma

Scoring Selection Criteria Including Total Tumour Volume And Pretransplant Percentage Of Lymphocytes To Predict Recurrence Of Hepatocellular Carcinoma After Liver Transplantation

[Multivariate Analysis of Recurrence of Hepatocellular Carcinoma after Liver Transplantation].

Association Between Tumor Size and Prognosis of Patients with Hepatocellular Carcinoma after Hepatectomy

Analysis of the Risk Factors Influencing the Prognosis of Orthotopic Liver Transplantation for Hepatocellular Carcinoma and Summary of Relevant Clinical Experience

A Model Combining TNM Stage and Tumor Size Shows Utility in Predicting Recurrence among Patients with Hepatocellular Carcinoma after Resection.

Preoperative CT analysis of multi-factors influencing the prognosis of patients with primary hepatocellular carcinoma after radical hepatectomy

Tumor Necrosis As a Poor Prognostic Predictor on Postoperative Survival of Patients with Solitary Small Hepatocellular Carcinoma

Analysis of prognostic factors of more/equal to10 years of survival for liver cancer patients after liver transplantation

Effect of Tumor Size on Cancer-Specific Survival in Small Hepatocellular Carcinoma

Long-term Survival and Risk Factors of Prognosis after Liver Transplantation for Malignant Liver Tumors

CT Volumetry Helps Predict Prognosis of Large Hepatocellular Carcinoma after Resection.

Expanded Criterion for Hepatocellular Carcinoma in Liver Transplantation